Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said on Thursday.
It, however, clarified that both doses administered to an individual should be of the same vaccine as per the existing protocol.
The clarification comes following reports that health workers in Uttar Pradesh's Siddharthnagar district administered Covaxin to 20 villagers who had been given Covishield in the first dose.
NITI Aayog member (Health) V K Paul said the incident needed to be investigated.
"Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is given. In fact, there is a narrative that is going on that taking doses of two different vaccines can lead to stronger immunity... but for a firm opinion, more scrutiny and understanding will be required, he said at a presser.
Commenting on the UP incident, he said, "Even if it has happened, it should not be a cause of concern for the individual, but I urge all health workers to give second dose of the same vaccine.
The incident was reported from the primary health centre in Barhni where people from Audahi Kala and another village received Covaxin shots on May 14.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)